Proteases and their inhibitors are indicative in gestational disease

Kolben M, Lopens A, Blaser J, Ulm K, Schmitt M, Schneider KTM, Tschesche H (1996)
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 68(1-2): 59-65.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Abstract / Bemerkung
Objective: To assess whether various proteolytic factors which are involved in trophoblast invasion show different concentrations in plasma and placenta of patients with HELLP syndrome, pre-/eclampsia and highly pathological Doppler flow measurements but without additional complications (hpD). Design. Cab control and observational study; 18 women with HELLP syndrome; 21 with pre-/eclampsia, 13 with hpD, as well as healthy pregnant women (matched pairs); statistical analysis: sign test and Wilcoxon test. Results: Urokinase-type plasminogen activator (uPA), uPA receptor, tissue-type plasminogen activator (tPA), plasminogen activator inhibitor 1 (PAI-1), matrix metalloproteinases MMP-8, MMP-9 and tissue inhibitor of metalloproteinases TIMP-1 were measured by ELISA. PAI-1 plasma levels are significantly elevated in all three groups studied. In HELLP syndrome, tPA and TIMP-1 are also elevated, and in patients with hpD, MMP-8 is increased, whereas MMP-9, and TIMP-1 are lower. In placenta extract, only pre-/eclampsia shows reduced MMP-9 concentrations. Conclusions: The increased frequency of small-for-gestational-age infants observed in all three study groups is an expression of impaired placental implantation and remodelling processes. These disturbances manifest themselves in the form of changes in some of the factors in plasma and placenta extract that are involved in these processes.
Erscheinungsjahr
Zeitschriftentitel
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Band
68
Zeitschriftennummer
1-2
Seite
59-65
ISSN
PUB-ID

Zitieren

Kolben M, Lopens A, Blaser J, et al. Proteases and their inhibitors are indicative in gestational disease. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 1996;68(1-2):59-65.
Kolben, M., Lopens, A., Blaser, J., Ulm, K., Schmitt, M., Schneider, K. T. M., & Tschesche, H. (1996). Proteases and their inhibitors are indicative in gestational disease. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 68(1-2), 59-65. doi:10.1016/0301-2115(96)02484-0
Kolben, M., Lopens, A., Blaser, J., Ulm, K., Schmitt, M., Schneider, K. T. M., and Tschesche, H. (1996). Proteases and their inhibitors are indicative in gestational disease. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 68, 59-65.
Kolben, M., et al., 1996. Proteases and their inhibitors are indicative in gestational disease. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 68(1-2), p 59-65.
M. Kolben, et al., “Proteases and their inhibitors are indicative in gestational disease”, EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol. 68, 1996, pp. 59-65.
Kolben, M., Lopens, A., Blaser, J., Ulm, K., Schmitt, M., Schneider, K.T.M., Tschesche, H.: Proteases and their inhibitors are indicative in gestational disease. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 68, 59-65 (1996).
Kolben, M, Lopens, A, Blaser, J, Ulm, K, Schmitt, M, Schneider, KTM, and Tschesche, Harald. “Proteases and their inhibitors are indicative in gestational disease”. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 68.1-2 (1996): 59-65.

27 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Transcriptional Dynamics of Cultured Human Villous Cytotrophoblasts.
Robinson JF, Kapidzic M, Gormley M, Ona K, Dent T, Seifikar H, Hamilton EG, Fisher SJ., Endocrinology 158(6), 2017
PMID: 28323933
Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9.
Jorge Neto SD, Machado JS, Araujo Júnior E, Palei AC, Amaral LM, Tanus-Santos JE, Marcolin AC, Duarte G, Sandrim VC, Cavalli RC., J Matern Fetal Neonatal Med 29(24), 2016
PMID: 26857587
Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion.
Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu W, Zhou R., J Perinatol 35(1), 2015
PMID: 25078863
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR, Palei AC, Sandrim VC, Amaral LM, Machado JS, Lacchini R, Cavalli RC, Duarte G, Tanus-Santos JE., Pharmacogenomics J 14(6), 2014
PMID: 24913092
Prediction of preeclampsia-bench to bedside.
Acharya A, Brima W, Burugu S, Rege T., Curr Hypertens Rep 16(11), 2014
PMID: 25239543
Matrix metalloproteinases as drug targets in preeclampsia.
Palei AC, Granger JP, Tanus-Santos JE., Curr Drug Targets 14(3), 2013
PMID: 23316964
Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.
Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, Ni W, Kalluri R, Werb Z., Proc Natl Acad Sci U S A 110(27), 2013
PMID: 23776237
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Lacchini R, Duarte G, Tanus-Santos JE., Pharmacogenomics J 12(6), 2012
PMID: 21769110
The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome.
Guven S, Sonmez M, Karahan SC., Hypertens Pregnancy 30(3), 2011
PMID: 19943771
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening.
Farina A, Zucchini C, De Sanctis P, Morano D, Sekizawa A, Purwosunu Y, Okai T, Rizzo N., Prenat Diagn 31(2), 2011
PMID: 21268038
Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia.
Wang Z, Lu S, Liu C, Zhao B, Pei K, Tian L, Ma X., Gynecol Endocrinol 26(2), 2010
PMID: 19724956
Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.
Becher N, Hein M, Danielsen CC, Uldbjerg N., Reprod Biol Endocrinol 8(), 2010
PMID: 20868473
Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy.
Montagnana M, Lippi G, Albiero A, Scevarolli S, Salvagno GL, Franchi M, Guidi GC., J Clin Lab Anal 23(2), 2009
PMID: 19288452
Placental expression of proteases and their inhibitors in patients with HELLP syndrome.
von Steinburg SP, Krüger A, Fischer T, Mario Schneider KT, Schmitt M., Biol Chem 390(11), 2009
PMID: 19663680
Molecular mechanisms of preeclampsia.
Mutter WP, Karumanchi SA., Microvasc Res 75(1), 2008
PMID: 17553534
Genetic and epigenetic factors contribute to the onset of preeclampsia.
Chelbi ST, Vaiman D., Mol Cell Endocrinol 282(1-2), 2008
PMID: 18177994
Adrenomedullin enhances invasion by trophoblast cell lines.
Zhang X, Green KE, Yallampalli C, Dong YL., Biol Reprod 73(4), 2005
PMID: 15917349
Matrix-metalloproteinase activity in first trimester placental bed biopsies in further complicated and uncomplicated pregnancies.
Huisman MA, Timmer A, Zeinstra M, Serlier EK, Hanemaaijer R, Goor Hv, Erwich JJ., Placenta 25(4), 2004
PMID: 15028416
Urokinase plasminogen activator (uPA) and its receptor (uPAR) in gestational tissues; Measurements and clinical implications.
Uszyński M, Perlik M, Uszyński W, Zekanowska E., Eur J Obstet Gynecol Reprod Biol 114(1), 2004
PMID: 15099871
Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts.
Sawicki G, Radomski MW, Winkler-Lowen B, Krzymien A, Guilbert LJ., Biol Reprod 63(5), 2000
PMID: 11058543
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S., Ann N Y Acad Sci 878(), 1999
PMID: 10415733
Reactivity and assay restriction profiles of monoclonal and polyclonal antibodies to acid phosphatases: a preliminary study.
Bull H, Choy M, Manyonda I, Brown CA, Waldron EE, Holmes SD, Booth JC, Nelson PN., Immunol Lett 70(3), 1999
PMID: 10656666

25 References

Daten bereitgestellt von Europe PubMed Central.

Placental bed spiral arteries in the hypertensive disorders of pregnancy.
Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A., Br J Obstet Gynaecol 98(7), 1991
PMID: 1883787
Preeclampsia, delivery, and the hemostatic system.
Saleh AA, Bottoms SF, Welch RA, Ali AM, Mariona FG, Mammen EF., Am. J. Obstet. Gynecol. 157(2), 1987
PMID: 2441602
The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy.
el-Roeiy A, Myers SA, Gleicher N., Am. J. Obstet. Gynecol. 164(5 Pt 1), 1991
PMID: 2035568
Endothelial function in normal and pre-eclamptic pregnancy: a hypothesis
Zeeman, Eur J Obstet Gynaecol Reprod Biol 43(), 1992
Adhesive and degradative properties of human placental cytotrophoblast cells in vitro.
Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J, Damsky CH., J. Cell Biol. 109(2), 1989
PMID: 2474556
Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts.
Feinberg RF, Kao LC, Haimowitz JE, Queenan JT Jr, Wun TC, Strauss JF 3rd, Kliman HJ., Lab. Invest. 61(1), 1989
PMID: 2473276
Tumour biology. Membrane proteases in focus.
Vassalli JD, Pepper MS., Nature 370(6484), 1994
PMID: 8015594
[Changes in fibrinolysis-associated parameters in HELLP syndrome]
Kolben M, Lopens A, Schmitt M, Schneider KT, Graeff H., Geburtshilfe Frauenheilkd 54(5), 1994
PMID: 8050684
Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole.
Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B., Br J Obstet Gynaecol 100(4), 1993
PMID: 8494839
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness
Blasi, Fibrinolysis 7(Suppl 1), 1993
Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.
Gilabert J, Estelles A, Ridocci F, Espana F, Aznar J, Galbis M., Gynecol. Obstet. Invest. 30(2), 1990
PMID: 2147163
Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?
Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F., Thromb. Haemost. 66(4), 1991
PMID: 1796389
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espna F, Loskutoff DJ, Schleef RR., Blood 84(1), 1994
PMID: 8018914
92-kD type IV collagenase mediates invasion of human cytotrophoblasts.
Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ., J. Cell Biol. 113(2), 1991
PMID: 1849141

AUTHOR UNKNOWN, 0
Serum collagenase levels during pregnancy and parturition.
Osmers R, Tschesche H, Rath W, Szeverenyi M, Suwer V, Wolker I, Kuhn W., Eur. J. Obstet. Gynecol. Reprod. Biol. 53(1), 1994
PMID: 8187921
Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma.
Zucker S, Lysik RM, Gurfinkel M, Zarrabi MH, Stetler-Stevenson W, Liotta LA, Birkedal-Hansen H, Mann W., J. Immunol. Methods 148(1-2), 1992
PMID: 1373424
Influence of delivery on plasminogen activator inhibitor activity.
Koelbl H, Kirchheimer J, Tatra G., J Perinat Med 17(2), 1989
PMID: 2681664
Inhibitors and activators of fibrinolysis during and after childbirth in maternal and cord blood.
Runnebaum IB, Maurer SM, Daly L, Bonnar J., J Perinat Med 17(2), 1989
PMID: 2509671
Tissue inhibitor of metalloproteinases: serum levels during pregnancy and labor, term and preterm.
Clark IM, Morrison JJ, Hackett GA, Powell EK, Cawston TE, Smith SK., Obstet Gynecol 83(4), 1994
PMID: 8134062

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 8886683
PubMed | Europe PMC

Suchen in

Google Scholar